Männedorf, Switzerland – The Tecan Group (SIX Swiss Exchange: TECN) today announced an OEM agreement with DiaSorin for the supply of a fully automated clinical ELISA platform and certain detection instruments to be used in conjunction with DiaSorin’s MUREX product line for the diagnosis of HIV, HCV and HBV infections. The OEM agreement covers all […]
AUSTIN, TX – Asuragen, Inc., a leader in the development of molecular diagnostics, announced today at the 29th Annual JP Morgan Healthcare Conference in San Francisco that it had received Notices of Allowance from the United States Patent and Trademark Office (“USPTO”) for claims related to the use of mir-21 and mir-30a as diagnostics in […]
Germantown, MD., and Hilden, Germany – QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) has signed an agreement for the acquisition of a strategic stake in Alacris Theranostics GmbH, a German start-up company using novel technologies to develop individualized cancer treatment strategies based upon a patient’s genomic profile, and for the acquisition of an exclusive option […]
BASEL, Switzerland – EyeSense AG, a leading developer of novel ophthalmic self-diagnostic systems for glucose monitoring of diabetes patients, today announced that it has entered into a strategic partnership with QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA). Capitalizing on QIAGEN’s ESE fluorescence-based optical technology and on Eyesense’s glucose sensing technology, the partners intend to develop […]
LabChip Dx Provides Rapid, Accurate and Cost Effective Advanced Nucleic Acid Separations Capability to Clinical Research Laboratories HOPKINTON, Mass. – Caliper Life Sciences, Inc. (Nasdaq: CALP) today announced the launch of Caliper’s new, innovative LabChip Dx system for use by clinical research laboratories developing molecular diagnostic tests. The LabChip Dx platform is now available in […]
Männedorf, Switzerland – The Tecan Group (SIX Swiss Exchange: TECN), a leading global provider of laboratory instruments and solutions, and Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics company, announced today the signing of a licence and collaboration agreement. The licence provides Tecan with access to specific Enigma intellectual property that is used in […]
WALTHAM, Mass. – On-Q-ity, a next-generation oncology diagnostics company developing personalized and predictive tests to improve cancer therapy effectiveness, today announced a strategic alliance with Laboratory Corporation of America Holdings® (LabCorp). LabCorp will market On-Q-ity’s novel and proprietary circulating tumor cell (CTC) platform to the biopharma industry to greatly accelerate and improve the cancer drug […]
LEXINGTON, Mass. – T2 Biosystems, Inc., a company developing next-generation medical diagnostic products, today announced that it has relocated to a newly renovated 20,000 sq.ft. facility located in Lexington, MA. T2 Biosystems’ new facility in Lexington is more than twice the size of the company’s existing space in Cambridge, and the new space will accommodate […]
SAN DIEGO – Sequenom (Nasdaq: SQNM) today announced the appointment of William (Bill) Welch to the position of senior vice president of diagnostics. Mr. Welch will report to Harry F. Hixson, Jr., Ph.D. chairman and CEO of Sequenom, and he will be responsible for all commercial aspects of the company’s diagnostics business. “Bill has an […]
Jena – Analytik Jena AG (Frankfurt DE0005213508, Prime Standard: AJA) has increased its stake in subsidiary AJ Innuscreen GmbH to 100.0% and is now its sole owner. Thus, the Jena-based manufacturer of analytical instrumentation technology is continuing its strategic course of stepping up its life cycle business. “With its high level of investment in the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
